Animal models for vascular tissue-engineering

Current Opinion in Biotechnology

Volumn 24, Issue 5, 2013, Pages 916-925

  Swartz, Daniel D ^a   Andreadis, Stelios T ^a,b,c  

^a UNIVERSITY AT BUFFALO   (United States)

^b State University of New York   (United States)

^c University at Buffalo SUNY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; CARDIO-VASCULAR DISEASE; CLINICAL TRIAL; CLINICAL USE; HUMAN PHYSIOLOGY; SMALL ANIMAL MODEL; TESTING PLATFORMS; VASCULAR GRAFTS;

BLOOD VESSELS;

TISSUE ENGINEERING;

ANIMAL EXPERIMENT; ANIMAL MODEL; BIODEGRADABILITY; BLOOD VESSEL FUNCTION; BLOOD VESSEL GRAFT; BLOOD VESSEL TRANSPLANTATION; CAPRINE MODEL; CELL DIFFERENTIATION; CLINICAL STUDY; EXPERIMENTAL ANIMAL; EXPERIMENTAL DOG; EXPERIMENTAL MODEL; EXPERIMENTAL RABBIT; IMMUNOGENICITY; MEDICAL RESEARCH; MESENCHYMAL STEM CELL; MOUSE MODEL; NONHUMAN; PLURIPOTENT STEM CELL; PORCINE MODEL; PRIMATE; PRIORITY JOURNAL; RAT MODEL; REVIEW; SHEEP; TISSUE ENGINEERING; VASCULAR PATENCY; VASCULAR TISSUE;

ANIMALIA;

EID: 84884417597     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2013.05.005     Document Type: Review

References (64)

1. Ricotta J. Vascular conduits. Vascular Surgery 2005, Elsevier Saunders. R.B. Rutherford (Ed.).
2. Gaudino M., Cellini C., Pragliola C., Trani C., Burzotta F., Schiavoni G., Nasso G., Possati G. Arterial versus venous bypass grafts in patients with in-stent restenosis. Circulation 2005, 112:I265-I269.
3. Conte M.S. The ideal small arterial substitute: a search for the Holy Grail?. FASEB J 1998, 12:43-45.
4. Niklason L.E., Gao J., Abbott W.M., Hirschi K.K., Houser S., Marini R., Langer R. Functional arteries grown in vitro. Science 1999, 284:489-493.
5. L'Heureux N., Paquet S., Labbe R., Germain L., Auger F.A. A completely biological tissue-engineered human blood vessel. FASEB J 1998, 12:47-56.
6. L'Heureux N., Dusserre N., Konig G., Victor B., Keire P., Wight T.N., Chronos N.A., Kyles A.E., Gregory C.R., Hoyt G., et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 2006, 12:361-365.
7. Roh J.D., Sawh-Martinez R., Brennan M.P., Jay S.M., Devine L., Rao D.A., Yi T., Mirensky T.L., Nalbandian A., Udelsman B., et al. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci U S A 2010, 107:4669-4674.
8. Dahl S.L., Kypson A.P., Lawson J.H., Blum J.L., Strader J.T., Li Y., Manson R.J., Tente W.E., DiBernardo L., Hensley M.T., et al. Readily available tissue-engineered vascular grafts. Sci Transl Med 2011, 3. 68ra69.
9. Syedain Z.H., Meier L.A., Bjork J.W., Lee A., Tranquillo R.T. Implantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring. Biomaterials 2011, 32:714-722.
10. Isenberg B.C., Williams C., Tranquillo R.T. Small-diameter artificial arteries engineered in vitro. Circ Res 2006, 98:25-35.
11. Peng H., Schlaich E.M., Row S., Andreadis S.T., Swartz D.D. A novel ovine ex vivo arteriovenous shunt model to test vascular implantability. Cells Tissues Organs 2012, 195:108-121.
12. Liu J.Y., Swartz D.D., Peng H.F., Gugino S.F., Russell J.A., Andreadis S.T. Functional tissue-engineered blood vessels from bone marrow progenitor cells. Cardiovasc Res 2007, 75:618-628.
13. Swartz D.D., Russell J.A., Andreadis S.T. Engineering of fibrin-based functional and implantable small-diameter blood vessels. Am J Physiol Heart Circ Physiol 2005, 288:H1451-H1460.
14. Gong Z., Niklason L.E. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J 2008, 22:1635-1648.
15. Bierman E.L. The effect of donor age on the in vitro life span of cultured human arterial smooth-muscle cells. In Vitro 1978, 14:951-955.
16. Poh M., Boyer M., Solan A., Dahl S.L., Pedrotty D., Banik S.S., McKee J.A., Klinger R.Y., Counter C.M., Niklason L.E. Blood vessels engineered from human cells. Lancet 2005, 365:2122-2124.
17. Seruya M., Shah A., Pedrotty D., du Laney T., Melgiri R., McKee J.A., Young H.E., Niklason L.E. Clonal population of adult stem cells: life span and differentiation potential. Cell Transplant 2004, 13:93-101.
18. Karp J.M., Leng Teo G.S. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 2009, 4:206-216.
19. Zhou S., Greenberger J.S., Epperly M.W., Goff J.P., Adler C., Leboff M.S., Glowacki J. Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell 2008, 7:335-343.
20. Baxter M.A., Wynn R.F., Jowitt S.N., Wraith J.E., Fairbairn L.J., Bellantuono I. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 2004, 22:675-682.
21. Han J., Liu J.Y., Swartz D.D., Andreadis S.T. Molecular and functional effects of organismal ageing on smooth muscle cells derived from bone marrow mesenchymal stem cells. Cardiovasc Res 2010, 87:147-155.
22. Han J., Mistriotis P., Lei P., Wang D., Liu S., Andreadis S.T. Nanog reverses the effects of organismal aging on mesenchymal stem cell proliferation and myogenic differentiation potential. Stem Cells 2012, 30:2746-2759.
23. Bajpai V.K., Mistriotis P., Loh Y.H., Daley G.Q., Andreadis S.T. Functional vascular smooth muscle cells derived from human induced pluripotent stem cells via mesenchymal stem cell intermediates. Cardiovasc Res 2012, 96:391-400.
24. Liu J.Y., Peng H.F., Andreadis S.T. Contractile smooth muscle cells derived from hair-follicle stem cells. Cardiovasc Res 2008, 79:24-33.
25. Liu J.Y., Peng H.F., Gopinath S., Tian J., Andreadis S.T. Derivation of functional smooth muscle cells from multipotent human hair follicle mesenchymal stem cells. Tissue Eng Part A 2010, 16:2553-2564.
26. Bajpai V.K., Mistriotis P., Andreadis S.T. Clonal multipotency and effect of long-term in vitro expansion on differentiation potential of human hair follicle derived mesenchymal stem cells. Stem Cell Res 2012, 8:74-84.
27. Koobatian M., Liang M.S., Swartz D.D., Andreadis S.T. Differential effects of pulsatile pressure on contractile function of neonatal vs. adult mesenchymal stem cells 2013, (in preparation).
28. Bajpai V.K., Andreadis S.T. Stem cell sources for vascular tissue engineering and regeneration. Tissue Eng Part B Rev 2012, 18:405-425.
29. Cardiovascular implants-tubular prostheses 1998, Standardization IOf (Ed.).
30. Association for the Advancement of Medical Instrumentation, Cardiovascular implants-vascular graft prostheses 2000, Standard AN (Ed.).
31. Abbott W.M., Callow A., Moore W., Rutherford R., Veith F., Weinberg S. Evaluation and performance standards for arterial prostheses. J Vasc Surg 1993, 17:746-756.
32. Row S., Peng H.F., Schlaich E.M., Andreadis S.T., Swartz D.D. Arterial implantation of tissue engineered blood vessels from mesenchymal stem cells in an ovine animal model 2013, (in preparation).
33. Koch S., Flanagan T.C., Sachweh J.S., Tanios F., Schnoering H., Deichmann T., Ella V., Kellomaki M., Gronloh N., Gries T., et al. Fibrin-polylactide-based tissue-engineered vascular graft in the arterial circulation. Biomaterials 2010, 31:4731-4739.
34. Tillman B.W., Yazdani S.K., Neff L.P., Corriere M.A., Christ G.J., Soker S., Atala A., Geary R.L., Yoo J.J. Bioengineered vascular access maintains structural integrity in response to arteriovenous flow and repeated needle puncture. J Vasc Surg 2012, 56:783-793.
35. Peirovi H., Rezvani N., Hajinasrollah M., Mohammadi S.S., Niknejad H. Implantation of amniotic membrane as a vascular substitute in the external jugular vein of juvenile sheep. J Vasc Surg 2012, 56:1098-1104.
36. Cummings I., George S., Kelm J., Schmidt D., Emmert M.Y., Weber B., Zund G., Hoerstrup S.P. Tissue-engineered vascular graft remodeling in a growing lamb model: expression of matrix metalloproteinases. Eur J Cardiothorac Surg 2012, 41:167-172.
37. Hoerstrup S.P., Cummings Mrcs I., Lachat M., Schoen F.J., Jenni R., Leschka S., Neuenschwander S., Schmidt D., Mol A., Gunter C., et al. Functional growth in tissue-engineered living, vascular grafts: follow-up at 100 weeks in a large animal model. Circulation 2006, 114:I159-I166.
38. Quint C., Kondo Y., Manson R.J., Lawson J.H., Dardik A., Niklason L.E. Decellularized tissue-engineered blood vessel as an arterial conduit. Proc Natl Acad Sci U S A 2011, 108:9214-9219.
39. Robotin-Johnson M.C., Swanson P.E., Johnson D.C., Schuessler R.B., Cox J.L. An experimental model of small intestinal submucosa as a growing vascular graft. J Thorac Cardiovasc Surg 1998, 116:805-811.
40. Watanabe M., Shin'oka T., Tohyama S., Hibino N., Konuma T., Matsumura G., Kosaka Y., Ishida T., Imai Y., Yamakawa M., et al. Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model. Tissue Eng 2001, 7:429-439.
41. Zhou M., Liu Z., Liu C., Jiang X., Wei Z., Qiao W., Ran F., Wang W., Qiao T., Liu C. Tissue engineering of small-diameter vascular grafts by endothelial progenitor cells seeding heparin-coated decellularized scaffolds. J Biomed Mater Res B Appl Biomater 2012, 100:111-120.
42. Cassel W.S., Mason R.A., Campbell R., Newton G.B., Hui J.C., Giron F. An animal model for small-diameter arterial grafts. J Invest Surg 1989, 2:181-186.
43. Sparks S.R., Tripathy U., Broudy A., Bergan J.J., Kumins N.H., Owens E.L. Small-caliber mesothelial cell-layered polytetraflouroethylene vascular grafts in New Zealand white rabbits. Ann Vasc Surg 2002, 16:73-76.
44. Chaouat M., Le Visage C., Autissier A., Chaubet F., Letourneur D. The evaluation of a small-diameter polysaccharide-based arterial graft in rats. Biomaterials 2006, 27:5546-5553.
45. Hwang S.J., Kim S.W., Choo S.J., Lee B.W., Im I.R., Yun H.J., Lee S.K., Song H., Cho W.C., Lee J.W. The decellularized vascular allograft as an experimental platform for developing a biocompatible small-diameter graft conduit in a rat surgical model. Yonsei Med J 2011, 52:227-233.
46. Lopez-Soler R.I., Brennan M.P., Goyal A., Wang Y., Fong P., Tellides G., Sinusas A., Dardik A., Breuer C. Development of a mouse model for evaluation of small diameter vascular grafts. J Surg Res 2007, 139:1-6.
47. Hibino N., Yi T., Duncan D.R., Rathore A., Dean E., Naito Y., Dardik A., Kyriakides T., Madri J., Pober J.S., et al. A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts. FASEB J 2011, 12:4253-4263.
48. Shin'oka T., Imai Y., Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 2001, 344:532-533.
49. Shin'oka T., Matsumura G., Hibino N., Naito Y., Watanabe M., Konuma T., Sakamoto T., Nagatsu M., Kurosawa H. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 2005, 129:1330-1338.
50. Hibino N., McGillicuddy E., Matsumura G., Ichihara Y., Naito Y., Breuer C., Shinoka T. Late-term results of tissue-engineered vascular grafts in humans. J Thorac Cardiovasc Surg 2010, 139:431-440.
51. L'Heureux N., McAllister T.N., de la Fuente L.M. Tissue-engineered blood vessel for adult arterial revascularization. N Engl J Med 2007, 357:1451-1453.
52. McAllister T.N., Maruszewski M., Garrido S.A., Wystrychowski W., Dusserre N., Marini A., Zagalski K., Fiorillo A., Avila H., Manglano X., et al. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 2009, 373:1440-1446.
53. Hibino N., McGillicuddy E., Matsumura G., Ichihara Y., Naito Y., Breuer C., Shinoka T. Late-term results of tissue-engineered vascular grafts in humans. J Thorac Cardiovasc Surg 2010, 139:431-436. 436.e1-2.
54. Shinoka T., Shum-Tim D., Ma P.X., Tanel R.E., Isogai N., Langer R., Vacanti J.P., Mayer J.E. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg 1998, 115:536-545. discussion 545-36.
55. Leyh R.G., Wilhelmi M., Rebe P., Ciboutari S., Haverich A., Mertsching H. Tissue engineering of viable pulmonary arteries for surgical correction of congenital heart defects. Ann Thorac Surg 2006, 81:1466-1470. discussion 1470-61.
56. Hashi C.K., Zhu Y., Yang G.Y., Young W.L., Hsiao B.S., Wang K., Chu B., Li S. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci U S A 2007, 104:11915-11920.
57. Brennan M.P., Dardik A., Hibino N., Roh J.D., Nelson G.N., Papademitris X., Shinoka T., Breuer C.K. Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model. Ann Surg 2008, 248:370-377.
58. Cho S.W., Kim I.K., Kang J.M., Song K.W., Kim H.S., Park C.H., Yoo K.J., Kim B.S. Evidence for in vivo growth potential and vascular remodeling of tissue-engineered artery. Tissue Eng Part A 2009, 15:901-912.
59. Nieponice A., Soletti L., Guan J., Hong Y., Gharaibeh B., Maul T.M., Huard J., Wagner W.R., Vorp D.A. In vivo assessment of a tissue-engineered vascular graft combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a rat model. Tissue Eng Part A 2010, 16:1215-1223.
60. Zhao Y., Zhang S., Zhou J., Wang J., Zhen M., Liu Y., Chen J., Qi Z. The development of a tissue-engineered artery using decellularized scaffold and autologous ovine mesenchymal stem cells. Biomaterials 2010, 31:296-307.
61. Zhu B., Bailey S.R., Elliott J., Li X., Escobar G.P., Rodriguez E.M., Agrawal C.M. Development of a total atherosclerotic occlusion with cell-mediated calcium deposits in a rabbit femoral artery using tissue-engineering scaffolds. J Tissue Eng Regen Med 2012, 6:193-204.
62. Assmann A., Akhyari P., Delfs C., Flogel U., Jacoby C., Kamiya H., Lichtenberg A. Development of a growing rat model for the in vivo assessment of engineered aortic conduits. J Surg Res 2012, 176:367-375.
63. Janairo R.R., Henry J.J., Lee B.L., Hashi C.K., Derugin N., Lee R., Li S. Heparin-modified small-diameter nanofibrous vascular grafts. IEEE Trans Nanobiosci 2012, 11:22-27.
64. Akhmedov Sh D., Afanas'ev S.A., Egorova M.V., Andreev S.L., Ivanov A.V., Rogovskaia Y.V., Usov V.Y., Shvedov A.N., Steinhoff G. Cell-free collagen-based scaffolds used for making blood vessels in cardiovascular surgery. Angiol Sosud Khir 2012, 18:7-12.